ADVERTISEMENT
Illustration of a virus
Vaccines: Sex Matters
Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.
Vaccines: Sex Matters
Vaccines: Sex Matters

Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.

Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.

flu vaccine

Dead shark on concrete
Researchers Make Alternatives to Shark-Sourced Vaccine Ingredient
Natalia Mesa, PhD | Feb 22, 2023 | 3 min read
Synthetic variations of squalene, which is used to boost immune responses, could make vaccines more effective while reducing fisheries for struggling sharks.
An artistic rendering of SARS-CoV-2 made to look like stained glass
SARS-CoV-2 Infection Can Alter Future Immune Reponses
Niki Spahich, PhD | Feb 22, 2023 | 3 min read
Males recovered from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges.
3D rendered images of three T cell
T Cells Ward Off Aging with Help from Their Friends
Natalia Mesa, PhD | Sep 16, 2022 | 5 min read
Immune cells deliver packages of telomeres to T cells, helping them retain their virus-fighting function over time, research suggests.
Chickens in front of brown mesh coops
Bird Flu Hits US Hard
Natalia Mesa, PhD | Apr 8, 2022 | 3 min read
So far this season, tens of millions of birds have died of disease or been culled, driving up prices of eggs, chicken, and turkey meat.
a hand making a "stop" signal at an incoming coronavirus particle
Scientists’ Advice for Ways to Ward Off the Coronavirus
Shawna Williams | Oct 9, 2020 | 5 min read
We asked experts for measures people can take that may help boost defenses against COVID-19 and other respiratory diseases.
Alzheimer's Disease, Neurology, Influenza, Pneumonia, Vaccine, Pneumococcal, Immune System, Dementia
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer’s
Amanda Heidt | Jul 27, 2020 | 3 min read
The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.
Confronting a Pandemic, 1957
Catherine Offord | Jun 1, 2020 | 2 min read
Microbiologist Maurice Hilleman foresaw the global spread of a novel influenza strain in 1957. His vaccine saved hundreds of thousands of lives.
Flu Shot Ignites Immune Attack Against Cancer in Mice
Ashley Yeager | Apr 1, 2020 | 5 min read
Injecting the seasonal flu vaccine directly into clumps of malignant cells recruits immune cells to confront the cancer.
Gut Microbes Boost Flu Vaccine’s Success: Clinical Trial
Abby Olena, PhD | Sep 5, 2019 | 4 min read
Antibiotics disrupt the immune response to the influenza vaccine in people who haven’t recently had exposure to the virus or immunization.
First Universal Flu Vaccine to Enter Phase 3 Trial
Ashley P. Taylor | Nov 12, 2018 | 7 min read
Numerous experimental vaccines that aim to provide multi-season protection are in human studies.
This Flu Season Killed 172 Kids
Sukanya Charuchandra | Jun 11, 2018 | 1 min read
Vaccination reduced the risk of death by two-thirds for children with no other health problems.  
CDC: Flu Vaccine 36 Percent Effective So Far
Catherine Offord | Feb 16, 2018 | 2 min read
The vaccine shows better-than-expected effectiveness against the most common and most virulent strain of influenza in children under 9 years old.
Molecular Fingerprint Predicts Flu Shot Response
Jyoti Madhusoodanan | Jan 4, 2016 | 3 min read
A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show. 
When the Flu Vax Fails
Jef Akst | Dec 16, 2015 | 2 min read
The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 
Toward a Universal Flu Vax
Jef Akst | Oct 27, 2015 | 2 min read
Adding an adjuvant to stimulate both innate and adaptive immunity, researchers boost the effectiveness of an influenza A vaccine in mice.
Mutated Flu May Dodge Vaccine Protection
Molly Sharlach | Dec 8, 2014 | 2 min read
About half of the H3N2 influenza samples tested in the United States encode altered antigens from the strain used to produce this year’s vaccine.
Bacteria Boost Viral Vaccine Response
Jyoti Madhusoodanan | Sep 11, 2014 | 3 min read
Gut microbes enhance response to the seasonal flu shot in mice.
Flu Vaccine-Narcolepsy Link Explained?
Jef Akst | Dec 20, 2013 | 2 min read
A new study sheds light on why those who received GlaxoSmithKline’s flu vaccine were at an increased risk of developing the sleep disorder.
First Recombinant Flu Vaccine
Beth Marie Mole | Jan 21, 2013 | 1 min read
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
ADVERTISEMENT